Anti Cancer Capsules

Product Details:

Zanubrutinib (Brukinsa, 80 mg oral capsules) is a second-generation BTK inhibitor indicated for the treatment of adult patients with WM. It received a Notice of Compliance from Health Canada on March 1, 2021.

Product Details:

Pyrotinib maleate, also known as pyrotinib, is an irreversible dual receptor tyrosine kinase inhibitor that primarily targets the epidermal growth factor Pyrotinib is an irreversible pan-ErbB receptor tyrosine kinase inhibitor (TKI) drug targeting epidermal growth factor receptor (EGFR), HER1, HER2, and HER4 (Zhu et al., 2016; Li et al., 2017), and it has shown promising antitumor activities in patients with HER2-positive metastatic breast cancer according to the ...receptor (EGFR) and human epidermal growth factor receptor 2 (HER2).

Product Details:

Elunate® is for the treatment of patients with metastatic colorectal cancer (“CRC”) that have been previously treated with fluoropyrimidine, oxaliplatin and irinotecan, including those who have previously received or are unsuitable for anti-vascular endothelial growth factor (VEGF) therapy and/or anti-epidermal growth ..